Skip to content

EV / EBITDA at other companies

Eli Lilly logo
Eli LillyLLY
25.9×-24.4×
McKesson logo
McKessonMCK
16.1×-2.6×
Cencora logo
CencoraCOR
18.6×+2.4×
CVS Health logo
CVS HealthCVS
9.2×+2.7×
Abbott logo
AbbottABT
18.9×-4.1×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
21.5×-1.1×

Other financials

Income statement

See full
Revenue$60.9B+11.1%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.2%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$53B+49.4%
Enterprise value$57.98B+45.4%
P/E34.1×+11.3×
P/S0.2×+0.1×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp

Returns & leverage

See full
Return on equity37.4%
Debt / equity4.1×
Current ratio0.9×0.0×

Where this comes from

Calculated from Cardinal Health’s reported figures.

Based on the most recent quarter.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's EV / EBITDA?
Cardinal Health (CAH) reported EV / EBITDA of 16.9× in Q1 2026.
How has Cardinal Health's EV / EBITDA changed year-over-year?
Cardinal Health's EV / EBITDA increased by 35.4% year-over-year, from 12.5× to 16.9×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.